These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22768873)

  • 1. DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic.
    Roberts JA; De Waele JJ; Dimopoulos G; Koulenti D; Martin C; Montravers P; Rello J; Rhodes A; Starr T; Wallis SC; Lipman J
    BMC Infect Dis; 2012 Jul; 12():152. PubMed ID: 22768873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically relevant pharmacokinetic knowledge on antibiotic dosing among intensive care professionals is insufficient: a cross-sectional study.
    Fleuren LM; Roggeveen LF; Guo T; Waldauf P; van der Voort PHJ; Bosman RJ; Swart EL; Girbes ARJ; Elbers PWG
    Crit Care; 2019 May; 23(1):185. PubMed ID: 31118061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis.
    Chai MG; Tu Q; Cotta MO; Bauer MJ; Balch R; Okafor C; Comans T; Kruger P; Meyer J; Shekar K; Brady K; Fourie C; Sharp N; Vlad L; Whiley D; Ungerer JPJ; Mcwhinney BC; Farkas A; Paterson DL; Clark JE; Hajkowicz K; Raman S; Bialasiewicz S; Lipman J; Forde BM; Harris PNA; Schlapbach LJ; Coin L; Roberts JA; Irwin AD
    Intensive Care Med; 2024 Apr; 50(4):539-547. PubMed ID: 38478027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updated antimicrobial dosing recommendations for obese patients.
    Castro-Balado A; Varela-Rey I; Mejuto B; Mondelo-García C; Zarra-Ferro I; Rodríguez-Jato T; Fernández-Ferreiro A
    Antimicrob Agents Chemother; 2024 May; 68(5):e0171923. PubMed ID: 38526051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis.
    Chai MG; Tu Q; Cotta MO; Bauer MJ; Balch R; Okafor C; Comans T; Kruger P; Meyer J; Shekar K; Brady K; Fourie C; Sharp N; Vlad L; Whiley D; Ungerer JPJ; Mcwhinney BC; Farkas A; Paterson DL; Clark JE; Hajkowicz K; Raman S; Bialasiewicz S; Lipman J; Forde BM; Harris PNA; Schlapbach LJ; Coin L; Roberts JA; Irwin AD
    Intensive Care Med; 2024 May; 50(5):810. PubMed ID: 38563901
    [No Abstract]   [Full Text] [Related]  

  • 6. DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?
    Roberts JA; Paul SK; Akova M; Bassetti M; De Waele JJ; Dimopoulos G; Kaukonen KM; Koulenti D; Martin C; Montravers P; Rello J; Rhodes A; Starr T; Wallis SC; Lipman J;
    Clin Infect Dis; 2014 Apr; 58(8):1072-83. PubMed ID: 24429437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients.
    De Waele JJ; Lipman J; Akova M; Bassetti M; Dimopoulos G; Kaukonen M; Koulenti D; Martin C; Montravers P; Rello J; Rhodes A; Udy AA; Starr T; Wallis SC; Roberts JA
    Intensive Care Med; 2014 Sep; 40(9):1340-51. PubMed ID: 25053248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.
    Roberts JA; Abdul-Aziz MH; Lipman J; Mouton JW; Vinks AA; Felton TW; Hope WW; Farkas A; Neely MN; Schentag JJ; Drusano G; Frey OR; Theuretzbacher U; Kuti JL;
    Lancet Infect Dis; 2014 Jun; 14(6):498-509. PubMed ID: 24768475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort.
    Abdul-Aziz MH; Lipman J; Akova M; Bassetti M; De Waele JJ; Dimopoulos G; Dulhunty J; Kaukonen KM; Koulenti D; Martin C; Montravers P; Rello J; Rhodes A; Starr T; Wallis SC; Roberts JA;
    J Antimicrob Chemother; 2016 Jan; 71(1):196-207. PubMed ID: 26433783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the accuracy and precision of pharmacokinetic equations to predict free meropenem concentrations in critically ill patients.
    Wong G; Farkas A; Sussman R; Daroczi G; Hope WW; Lipman J; Roberts JA
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1411-7. PubMed ID: 25512414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study.
    Blot S; Koulenti D; Akova M; Bassetti M; De Waele JJ; Dimopoulos G; Kaukonen KM; Martin C; Montravers P; Rello J; Rhodes A; Starr T; Wallis SC; Lipman J; Roberts JA
    Crit Care; 2014 May; 18(3):R99. PubMed ID: 24887569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous beta-lactam infusion in critically ill patients: the clinical evidence.
    Abdul-Aziz MH; Dulhunty JM; Bellomo R; Lipman J; Roberts JA
    Ann Intensive Care; 2012 Aug; 2(1):37. PubMed ID: 22898246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal Dosing of Antibiotics: Are We Jumping the Gun?
    Crass RL; Rodvold KA; Mueller BA; Pai MP
    Clin Infect Dis; 2019 Apr; 68(9):1596-1602. PubMed ID: 30219824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial.
    Abdulla A; Ewoldt TMJ; Hunfeld NGM; Muller AE; Rietdijk WJR; Polinder S; van Gelder T; Endeman H; Koch BCP
    BMC Infect Dis; 2020 Jan; 20(1):57. PubMed ID: 31952493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study.
    Sinnollareddy MG; Roberts JA; Lipman J; Akova M; Bassetti M; De Waele JJ; Kaukonen KM; Koulenti D; Martin C; Montravers P; Rello J; Rhodes A; Starr T; Wallis SC; Dimopoulos G;
    Crit Care; 2015 Feb; 19(1):33. PubMed ID: 25888060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.
    Abdul-Aziz MH; Sulaiman H; Mat-Nor MB; Rai V; Wong KK; Hasan MS; Abd Rahman AN; Jamal JA; Wallis SC; Lipman J; Staatz CE; Roberts JA
    Intensive Care Med; 2016 Oct; 42(10):1535-1545. PubMed ID: 26754759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper
    Abdul-Aziz MH; Alffenaar JC; Bassetti M; Bracht H; Dimopoulos G; Marriott D; Neely MN; Paiva JA; Pea F; Sjovall F; Timsit JF; Udy AA; Wicha SG; Zeitlinger M; De Waele JJ; Roberts JA; ; ; ;
    Intensive Care Med; 2020 Jun; 46(6):1127-1153. PubMed ID: 32383061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial.
    De Waele JJ; Carrette S; Carlier M; Stove V; Boelens J; Claeys G; Leroux-Roels I; Hoste E; Depuydt P; Decruyenaere J; Verstraete AG
    Intensive Care Med; 2014 Mar; 40(3):380-7. PubMed ID: 24356862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Setting the Beta-Lactam Therapeutic Range for Critically Ill Patients: Is There a Floor or Even a Ceiling?
    Barreto EF; Webb AJ; Pais GM; Rule AD; Jannetto PJ; Scheetz MH
    Crit Care Explor; 2021 Jun; 3(6):e0446. PubMed ID: 34136822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT).
    Abdulla A; Dijkstra A; Hunfeld NGM; Endeman H; Bahmany S; Ewoldt TMJ; Muller AE; van Gelder T; Gommers D; Koch BCP
    Crit Care; 2020 Sep; 24(1):558. PubMed ID: 32933574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.